Atrial Fibrillation & the DECAAF trial– interviews Dr. Nassir Marrouche (Part 2 or 2)

In this video interview, Dr. Nassir Marrouche talked about the exciting research he and his team presented at Heart Rhythm 2010 that allows them to personalize atrial fibrillation (AF) treatment. They do catheter ablations and manage stroke prevention based on the amount of atrial fibrosis and atrial remodeling detected by MRI (magnetic resonance imaging). This fibrosis is characterized as Utah 1–4 stages and provides an indication of potential success, what treatments should be used, and the risk of stroke. Dr. Nassir Marrouche is Director of the University of Utah’s Electrophysiology Laboratories and Atrial Fibrillation Program, as well as Executive Director of the CARMA (Comprehensive Arrhythmia Research and Management) Center. See our recent article on this research at Personalized Atrial Fibrillation Treatment Using New Method to “Stage” AF at: See a full transcript of the interview at: Part 1 of 2 can be found at:

Leave a Reply

Fields marked with * are required.